Katie Meehan

12.4k total citations
51 papers, 1.1k citations indexed

About

Katie Meehan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Katie Meehan has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Katie Meehan's work include Extracellular vesicles in disease (10 papers), Cancer Genomics and Diagnostics (6 papers) and Reproductive System and Pregnancy (5 papers). Katie Meehan is often cited by papers focused on Extracellular vesicles in disease (10 papers), Cancer Genomics and Diagnostics (6 papers) and Reproductive System and Pregnancy (5 papers). Katie Meehan collaborates with scholars based in Australia, Hong Kong and United Kingdom. Katie Meehan's co-authors include Laura J. Vella, Lois A. Salamonsen, Natalie J. Hannan, Premila Paiva, Hugh Dawkins, John W. Holland, Luk Rombauts, Marianne D. Sadar, David K. Gardner and Adam Rainczuk and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Katie Meehan

51 papers receiving 1.1k citations

Peers

Katie Meehan

IMMUN

Darren Ennis United Kingdom

Martha Hayden-Ledbetter United States

Mu‐Hsien Yu Taiwan

Dwight D. Im United States

Jesús González Bosquet United States

Lyndal Anderson Australia

Beihua Kong China

Jesus Paula Carvalho Brazil

K M Feeley United Kingdom

Juan J. Roman United States

Darren Ennis United Kingdom

Katie Meehan

401 ×0.8

260 ×0.7

IMMUN

318 ×1.1

332 ×1.4

90 ×0.5

Citations per year, relative to Katie Meehan Katie Meehan (= 1×) peers Darren Ennis

Countries citing papers authored by Katie Meehan

Since Specialization

Citations

This map shows the geographic impact of Katie Meehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Meehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Meehan more than expected).

Fields of papers citing papers by Katie Meehan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Meehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Meehan. The network helps show where Katie Meehan may publish in the future.

Co-authorship network of co-authors of Katie Meehan

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Meehan. A scholar is included among the top collaborators of Katie Meehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Meehan. Katie Meehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meehan, Katie, et al.. (2025). The impact of genetics and the environment on cancer risk in Indigenous Australians: a narrative review. The Lancet Regional Health - Western Pacific. 61. 101627–101627. 1 indexed citations

Hayne, Dickon, Pravin Viswambaram, Elizabeth Liow, et al.. (2024). The SUB ‐urothelial DUrvalumab InjEction ‐1 ( SUBDUE ‐1) trial: first‐in‐human trial in patients with bladder cancer. British Journal of Urology. 134(2). 283–290. 3 indexed citations

Qu, Xinyu, Sai Ming Ngai, Sau‐Na Tsai, et al.. (2021). Proteomic Analysis of Circulating Extracellular Vesicles Identifies Potential Biomarkers for Lymph Node Metastasis in Oral Tongue Squamous Cell Carcinoma. Cells. 10(9). 2179–2179. 15 indexed citations

Wong, Nicholas C., Michael E. Clark, Stephen Q. Wong, et al.. (2021). Author Correction: Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer. Scientific Reports. 11(1). 15616–15616. 1 indexed citations

Wong, Nicholas C., Michael E. Clark, Stephen Q. Wong, et al.. (2021). Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer. Scientific Reports. 11(1). 4016–4016. 8 indexed citations

Clark, Michael E., et al.. (2020). Comparison of Circulating Tumour DNA and Extracellular Vesicle DNA by Low-Pass Whole-Genome Sequencing Reveals Molecular Drivers of Disease in a Breast Cancer Patient. Biomedicines. 9(1). 14–14. 20 indexed citations

Meehan, Katie, et al.. (2019). Laboratory validation studies in Ki-67 digital image analysis of breast carcinoma: a pathway to routine quality assurance. Pathology. 51(3). 246–252. 6 indexed citations

Conceição, A.L.C., Katie Meehan, M. Antoniassi, Marina Piacenti‐Silva, & M.E. Poletti. (2019). The influence of hydration on the architectural rearrangement of normal and neoplastic human breast tissues. Heliyon. 5(2). e01219–e01219. 8 indexed citations

Liang, James, Kathryn A. Fuller, Catherine Cole, et al.. (2018). Automated enumeration of lymphoid and plasma cells in bone marrow to establish normal reference ranges. Journal of Clinical Pathology. 71(10). 916–925. 7 indexed citations

10.

Dessauvagie, Benjamin F., Andrew H.S. Lee, Katie Meehan, et al.. (2018). Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology. Journal of Clinical Pathology. 71(8). 672–679. 19 indexed citations

11.

Dessauvagie, Benjamin F., Nathan T. Harvey, Richard J. N. Allcock, et al.. (2017). Detection of therapeutic targets in carcinomas of unknown primary. Annals of Oncology. 28. v597–v597. 1 indexed citations

12.

Fuller, Kathryn A., Jyoti Nangalia, Katie Meehan, et al.. (2015). Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. Journal of Clinical Pathology. 69(2). 155–163. 20 indexed citations

13.

Meehan, Katie & Laura J. Vella. (2015). The contribution of tumour-derived exosomes to the hallmarks of cancer. Critical Reviews in Clinical Laboratory Sciences. 53(2). 121–131. 110 indexed citations

14.

Fuller, Kathryn A., Wendy N. Erber, Katie Meehan, et al.. (2015). Mutational Analysis of BRAF Inhibitor–Associated Squamoproliferative Lesions. Journal of Molecular Diagnostics. 17(6). 644–651. 7 indexed citations

15.

Meehan, Katie, et al.. (2013). Developments in the immunophenotypic analysis of haematological malignancies. Blood Reviews. 27(4). 193–207. 9 indexed citations

16.

Menkhorst, Ellen, Amy Winship, Joanne Yap, et al.. (2012). Decidual-Secreted Factors Alter Invasive Trophoblast Membrane and Secreted Proteins Implying a Role for Decidual Cell Regulation of Placentation. PLoS ONE. 7(2). e31418–e31418. 48 indexed citations

17.

Rainczuk, Adam, Katie Meehan, David L. Steer, et al.. (2009). An optimized procedure for the capture, fractionation and proteomic analysis of proteins using hydrogel nanoparticles. PROTEOMICS. 10(2). 332–336. 10 indexed citations

18.

Meehan, Katie & Marianne D. Sadar. (2004). Quantitative profiling of LNCaP prostate cancer cells using isotope‐coded affinity tags and mass spectrometry. PROTEOMICS. 4(4). 1116–1134. 44 indexed citations

19.

Holland, John W., Katie Meehan, Sharon L. Redmond, & Hugh Dawkins. (2003). Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican. The Prostate. 59(3). 252–259. 11 indexed citations

20.

Cohen, Ronald J., John E. McNeal, Sharon L. Redmond, et al.. (2000). Luminal contents of benign and malignant prostatic glands: Correspondence to altered secretory mechanisms. Human Pathology. 31(1). 94–100. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact